FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:323-325 January 29, 1998 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Trapp, B. D. PubMed Citation

Virtually every textbook of neurology or general medicine includes chapters on demyelinating diseases, with most of the attention devoted to multiple sclerosis. The concept of multiple sclerosis as a demyelinating disease is deeply ingrained. The early description of multiple sclerosis by Charcot stressed the loss of myelin. The diagnosis of multiple sclerosis rests in part on the demonstration, by measurement of evoked potentials, of slowed action-potential conduction, a physiologic hallmark of demyelination.

The lipid-rich myelin sheath is produced by Schwann cells in peripheral nerves and by oligodendrocytes in the brain and spinal cord, and myelin possesses high electrical resistance and . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Lin, C. S.-Y., Macefield, V. G., Elam, M., Gunnar Wallin, B., Engel, S., Kiernan, M. C. (2007). Axonal changes in spinal cord injured patients distal to the site of injury. Brain 130: 985-994 [Abstract] [Full Text]  
• Howell, O. W., Palser, A., Polito, A., Melrose, S., Zonta, B., Scheiermann, C., Vora, A. J., Brophy, P. J., Reynolds, R. (2006). Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis. Brain 129: 3173-3185 [Abstract] [Full Text]  
• Kealey, S. M., Kim, Y., Whiting, W. L., Madden, D. J., Provenzale, J. M. (2005). Determination of Multiple Sclerosis Plaque Size with Diffusion-Tensor MR Imaging: Comparison Study with Healthy Volunteers. Radiology 236: 615-620 [Abstract] [Full Text]  
• Petzold, A, Eikelenboom, M J, Keir, G, Grant, D, Lazeron, R H C, Polman, C H, Uitdehaag, B M J, Thompson, E J, Giovannoni, G (2005). Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J. Neurol. Neurosurg. Psychiatry 76: 206-211 [Abstract] [Full Text]  
• Kerschensteiner, M., Bareyre, F. M., Buddeberg, B. S., Merkler, D., Stadelmann, C., Bruck, W., Misgeld, T., Schwab, M. E. (2004). Remodeling of Axonal Connections Contributes to Recovery in an Animal Model of Multiple Sclerosis. J. Exp. Med. 200: 1027-1038 [Abstract] [Full Text]  
• Filippi, M, Rocca, M A (2004). Cortical reorganisation in patients with MS. J. Neurol. Neurosurg. Psychiatry 75: 1087-1089 [Full Text]  
• Petzold, A, Rejdak, K, Plant, G T (2004). Axonal degeneration and inflammation in acute optic neuritis. J. Neurol. Neurosurg. Psychiatry 75: 1178-1180 [Abstract] [Full Text]  
• Kealey, S. M., Kim, Y., Provenzale, J. M. (2004). Redefinition of Multiple Sclerosis Plaque Size Using Diffusion Tensor MRI. Am. J. Roentgenol. 183: 497-503 [Abstract] [Full Text]  
• Craner, M. J., Newcombe, J., Black, J. A., Hartle, C., Cuzner, M. L., Waxman, S. G. (2004). Molecular changes in neurons in multiple sclerosis: Altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. Proc. Natl. Acad. Sci. USA 101: 8168-8173 [Abstract] [Full Text]  
• Hanak, S. E., Reilly, E. M., Wotanis, J., Zhu, B., Pulicicchio, C., McMonagle-Strucko, K., Wettstein, J. G., Black, M. D. (2004). An Electrophysiological Model of Spinal Transmission Deficits in Mouse Experimental Autoimmune Encephalomyelitis. J. Pharmacol. Exp. Ther. 308: 214-220 [Abstract] [Full Text]  
• Zoukos, Y, Thomaides, T N, Kidd, D, Cuzner, M L, Thompson, A (2003). Expression of {beta}2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study. J. Neurol. Neurosurg. Psychiatry 74: 197-202 [Abstract] [Full Text]  
• Lu, W., Bhasin, M., Tsirka, S. E. (2002). Involvement of Tissue Plasminogen Activator in Onset and Effector Phases of Experimental Allergic Encephalomyelitis. J. Neurosci. 22: 10781-10789 [Abstract] [Full Text]  
• Cappelen-Smith, C., Lin, C. S.-Y., Kuwabara, S., Burke, D. (2002). Conduction block during and after ischaemia in chronic inflammatory demyelinating polyneuropathy. Brain 125: 1850-1858 [Abstract] [Full Text]  
• Silber, E., Semra, Y. K., Gregson, N.A., Sharief, M. K. (2002). Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 58: 1372-1381 [Abstract] [Full Text]  
• Rambukkana, A., Zanazzi, G., Tapinos, N., Salzer, J. L. (2002). Contact-Dependent Demyelination by Mycobacterium leprae in the Absence of Immune Cells. Science 296: 927-931 [Abstract] [Full Text]  
• Guo, A. C., MacFall, J. R., Provenzale, J. M. (2002). Multiple Sclerosis: Diffusion Tensor MR Imaging for Evaluation of Normal-appearing White Matter. Radiology 222: 729-736 [Abstract] [Full Text]  
• Chang, A., Tourtellotte, W. W., Rudick, R., Trapp, B. D. (2002). Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis. NEJM 346: 165-173 [Abstract] [Full Text]  
• Guo, A. C., Jewells, V. L., Provenzale, J. M. (2001). Analysis of Normal-Appearing White Matter in Multiple Sclerosis: Comparison of Diffusion Tensor MR Imaging and Magnetization Transfer Imaging. Am. J. Neuroradiol. 22: 1893-1900 [Abstract] [Full Text]  
• Waxman, S. G. (2001). Acquired channelopathies in nerve injury and MS. Neurology 56: 1621-1627 [Abstract] [Full Text]  
• Brusa, A., Jones, S. J., Plant, G. T. (2001). Long-term remyelination after optic neuritis: A 2-year visual evoked potential and psychophysical serial study. Brain 124: 468-479 [Abstract] [Full Text]  
• Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., Weinshenker, B. G. (2000). Multiple Sclerosis. NEJM 343: 938-952 [Full Text]  
• Lev, M. H. (2000). Diffusion-weighted MR imaging of multiple sclerosis: added clinical value or "just another pretty face?".. Am. J. Neuroradiol. 21: 805-808 [Full Text]  
• Simon, J. H., Kinkel, R. P., Jacobs, L., Bub, L., Simonian, N. (2000). A Wallerian degeneration pattern in patients at risk for MS. Neurology 54: 1155-1160 [Abstract] [Full Text]  
• Rudkin, T. M., Arnold, D. L. (1999). Proton Magnetic Resonance Spectroscopy for the Diagnosis and Management of Cerebral Disorders. Arch Neurol 56: 919-926 [Abstract] [Full Text]  
• Osterhout, D. J., Wolven, A., Wolf, R. M., Resh, M. D., Chao, M. V. (1999). Morphological Differentiation of Oligodendrocytes Requires Activation of Fyn Tyrosine Kinase. J. Cell Biol. 145: 1209-1218 [Abstract] [Full Text]  
• McFarland, H. I., Lobito, A. A., Johnson, M. M., Nyswaner, J. T., Frank, J. A., Palardy, G. R., Tresser, N., Genain, C. P., Mueller, J. P., Matis, L. A., Lenardo, M. J. (1999). Determinant Spreading Associated with Demyelination in a Nonhuman Primate Model of Multiple Sclerosis. J. Immunol. 162: 2384-2390 [Abstract] [Full Text]  
• Arnold, D. L. (1998). The Axonal Hypothesis and Magnetic Resonance Spectroscopy of MS. Mult Scler 4: 499-500  
• Cannella, B., Hoban, C. J., Gao, Y.-L., Garcia-Arenas, R., Lawson, D., Marchionni, M., Gwynne, D., Raine, C. S. (1998). The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc. Natl. Acad. Sci. USA 95: 10100-10105 [Abstract] [Full Text]  
• Imaizumi, T., Lankford, K. L., Waxman, S. G., Greer, C. A., Kocsis, J. D. (1998). Transplanted Olfactory Ensheathing Cells Remyelinate and Enhance Axonal Conduction in the Demyelinated Dorsal Columns of the Rat Spinal Cord. J. Neurosci. 18: 6176-6185 [Abstract] [Full Text]